App-Quantinova.ai

PREVALENCE AND DETERMINANTS OF INTRA-STENT THROMBUS AFTER EVEROLIMUS-ELUTING STENT IMPLANTATION ASSESSED BY ANGIOSCOPY AND OPTICAL COHERENCE TOMOGRAPHY

Masamichi Iwasaki - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

PROGNOSTIC IMPACT OF MANAGEMENT IN PATIENTS WITH RENAL INSUFFICIENCY AND ACUTE CORONARY SYNDROME: FAST-MI 2010

Nicolas F. Meneveau - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

SPONTANEOUS ST-SEGMENT RESOLUTION IN STEMI PATIENTS CORRELATES WITH ENHANCED ENDOGENOUS THROMBOLYSIS USING A POINT-OF-CARE ASSAY

Christos Christopoulos - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and Visceral Aneurysms Repair: Italian Multicenter Registry Results at One Year Follow Up

maria antonella ruffino - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Biodegradable polymer-based Biolimus A9-eluting stent for the treatment of infrapopliteal arteries in critical limb ischemia: long-term clinical and angiographic follow-up

Eugenio Stabile - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

IVUS Predictors of Stent Thrombosis: Results From the Prospective, Multicenter ADAPT-DES Study

Akiko Maehara - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Use of IVUS Reduces Stent Thrombosis: Results from the Prospective, multicenter ADAPT-DES Study

Bernhard Witzenbichler - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Is the rate of femoral access site complications increased in the hands of radialists?

Stefano Rigattieri - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Antonio Bartorelli - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

Peter Smits - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in Patients with De Novo Coronary Artery Disease

Yoshinobu Onuma - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Two-Year Clinical Data Of Cohort 1 And Multi-Modality Imaging Results Up To 1-Year Follow-Up Of The BIOSOLVE-I Study With The Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)

Michael Haude - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroglycerin

LEADERS: 5-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Biodegradable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer- Final report of the LEADERS study

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Long Term Safety and Effectiveness of XIENCE V Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V USA Study

James Hermiller Jr - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Comparison of Polymer-Free BioFreedom Stents with Durable Polymer Taxus Liberte Stents: 3-Year Results from the BioFreedom First-In-Man Trial

Eberhard Grube - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

Clemens von Birgelen - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Two Year Follow-Up And Sub-group Analysis Of A Polymer-Free Sirolimus- And Probucol-Eluting Stent vs. A New Generation Zotarolimus-Eluting Stent In Coronary Artery Disease

Lamin King - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry

Renato Valenti - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Major Adverse Cardiac Events Associated With Discontinuation Of Clopidogrel Treatment Within The First Year After Coronary Stent Implantation In Western Denmark

Michael Maeng - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

PEPCAD-DES: A randomized, multicenter, single blinded trial comparing paclitaxel coated balloon angioplasty with plain balloon angioplasty in drug-eluting-stent restenosis 12 months results

Harald Rittger - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Filters

7277 Abstracts